Chongqing Pharscin Pharmaceutical Co., Ltd.
002907.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.45B
Close$
$11.19
26.7% downside
Current Fair Value
26.7% downsideOvervalued by 26.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.45 Billion |
|---|---|
| Enterprise Value | $6.20 Billion |
| Dividend Yield | $0.07 (0.49%) |
| Earnings per Share | $0.16 |
| Beta | -0.17 |
| Outstanding Shares | 417,596,314 |
Return
| Return on Equity | 4.27% |
|---|---|
| Return on Assets | 3.62% |
| Return on Invested Capital | 4.03% |
Valuation & Multiples
| P/E Ratio | 87.03 |
|---|---|
| PEG | 71.29 |
| Price to Sales | 15.27 |
| Price to Book Ratio | 3.82 |
| Enterprise Value to Revenue | 7.83 |
| Enterprise Value to EBIT | 85.64 |
| Enterprise Value to Net Income | 83 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chongqing Pharscin Pharmaceutical Co., Ltd.
1,439 employees
CEO: Xiaoying Liu Chongqing Pharscin Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the research, development, manufacturing, and distribution of medicines. Its product portfolio encompasses a broad spectrum of pharmaceu...